UNH vs CVS
UNH and CVS side by side — valuation & fundamentals (public data).
Key statistics
| Metric | UNHUnitedHealth Group Incorporated | CVSCVS HEALTH CORPORATION |
|---|---|---|
| Market cap | $352.72B | $119.03B |
| P/E (TTM) | 25.3 | 24.6 |
| P/B | 10.68 | 1.49 |
| P/S | 0.8x | 0.3x |
| Dividend yield | 2.24% | 2.85% |
| Revenue | $450.13B(TTM) | $415.09B(TTM) |
| Revenue growth (YoY) | 11.8% | 7.8% |
| Net income | $14.12B(TTM) | $4.89B(TTM) |
| Earnings growth (YoY) | -16.3% | -61.7% |
| EPS, diluted | $15.56(TTM) | $3.79(TTM) |
| EBIT margin | 4.2% | 1.2% |
| ROE | 36.5% | 2.2% |
| ROIC | 21.3% | 2.9% |
| Piotroski F | — | 6/9 |
| 1y total return | +32.9% | +32.7% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: UNH vs CVS
| Metric | UNH | CVS |
|---|---|---|
| End value | $35.1K | $12.4K |
| Total return | +250.6% | +23.9% |
| CAGR | +12.9% | +2.1% |
| Volatility | 29.9% | 28.7% |
| Sharpe | 0.43 | 0.08 |
| Sortino | 0.59 | 0.11 |
| Max drawdown | -61.4% | -56.8% |
Based on 2600 common trading days, 2016-04-27 → 2026-08-28 · risk-free 3.9% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)